Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Vaccine President Slot Opens Up With McGlynn's Retirement

This article was originally published in The Pink Sheet Daily

Executive Summary

A consummate Merck insider, Margie McGlynn, announces her plans to retire, as the company prepares for its pending merger with Schering-Plough.

You may also be interested in...



Merck Hires Former CDC Chief Julie Gerberding To Run Its Vaccine Division

In its second move in as many weeks to tap an outsider for a key position, Merck hired Julie Gerberding, a former director of the Centers for Disease Control and Prevention, as president of its vaccines division, effective as of Jan. 25, 2010

Merck Hires Former CDC Chief Julie Gerberding To Run Its Vaccine Division

In its second move in as many weeks to tap an outsider for a key position, Merck hired Julie Gerberding, a former director of the Centers for Disease Control and Prevention, as president of its vaccines division, effective as of Jan. 25, 2010

Merck Hires Julie Gerberding, A Former CDC Chief, To Run Its Vaccine Division

The big drug maker hires a high-profile physician with a public-health pedigree to boost its stagnant vaccine division.

Related Content

Topics

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel